L Lian, XL Li, MD Xu, XM Li, MY Wu,
Y Zhang, M Tao… - BMC cancer, 2019 - Springer
Background VEGF/VEGFR2 pathway is the central therapeutic target in anti-angiogenic
treatment in multiple cancers. However, little work has been carried out concerning the pro …